Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)
Recall Number: D-0181-2020
Firm: Dr. Reddy's Laboratories, Inc.
Classification: Class II
Status: Completed
Report Date: 20191113
Initiation Date: 20191001
Termination Date:
Reason for Recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Product Description
Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)